NRC
National Research Corporation
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$21.53
+1.32%Year over year
Reported trailing growth
- Revenue
- -0.2%
- EBITDA
- -31.5%
- EBIT
- -46.9%
- EPS
- -65.7%
- Free cash flow
- +133.4%
- Operating cash flow
- +38.5%
Forward estimates
Based on analyst estimates
- Revenue
- +5.3%
- EBITDA
- +81.0%
- EPS
- +261.9%
Three-year CAGR
- Revenue
- -3.2%
- EBITDA
- -15.0%
- EBIT
- -21.4%
- Net income
- -28.5%
- EPS
- -25.9%
- Free cash flow
- -15.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026